Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.960
+0.090 (4.81%)
At close: Mar 13, 2026, 4:00 PM EDT
1.930
-0.030 (-1.53%)
After-hours: Mar 13, 2026, 5:02 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $2.8 million as of March 13, 2026. Its market cap has decreased by -48.19% in one year.
Market Cap
2.80M
Enterprise Value
-3.21M
1-Year Change
-48.19%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.33M to $2.80M, a decrease of -89.37%. That is a compound annual growth rate of -25.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 2.67M | -54.45% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.55M | 131.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HCW Biologics | 3.11M |
| XORTX Therapeutics | 3.08M |
| Dermata Therapeutics | 3.02M |
| Artelo Biosciences | 3.01M |
| Azitra | 2.92M |
| Enveric Biosciences | 2.66M |
| Scinai Immunotherapeutics | 2.60M |
| CDT Equity | 2.59M |